Загрузка...
Metformin suppresses proliferation and invasion of drug‐resistant breast cancer cells by activation of the Hippo pathway
Drug resistance limits the clinical efficacy of breast cancer therapies, and overexpression or activation of Yes‐associated protein (YAP) is common in drug‐resistant cancer cells. Thus, inhibition of YAP may reduce resistance to anti‐cancer drugs. Metformin (MET), a first‐line diabetes medication th...
Сохранить в:
| Опубликовано в: : | J Cell Mol Med |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
John Wiley and Sons Inc.
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7214175/ https://ncbi.nlm.nih.gov/pubmed/32281270 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.15241 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|